An established cell line, MGH-Ul, has been studied on the cell kinetics follow ing the treatment with triethylene thiophosphoramide (Thio Tepa), a potent alkylating agent for the bladder carcinoma. The cell cycle was elongated immediately after the drug treatment with a low dose, the main effect being seen in S phase, and recovered nearly to the control level 48 hr after the treatment. Although analysis of the cell cycle parameters disclosed slight differences between the treated and untreated cells, repeated exposures at 12 or 48 hr interval to the low concentration of the drug did not lead to enhancement nor decrement of the drug effect on the cells . In view of the above findings, experiments were made to study if the cidal effect of the drug would be affected by pretreatment with the low dose. Recent advances in investigation of the cell cycle have disclosed that alkylating agents keep some effects on the cell cycle, suggesting a cell cycle phase specificity of the agents. In general, alkylating agents induce a prolongation of DNA synthetic alkyl alkanesulfonates (Mauro and Madoc-Jones 1970) . In the present study, the high dose of Thio Tepa produced a cidal effect on both the untreated control cells and the first generation cells with the drug pretreatment.
MATERIALS AND METHODS
With the same manipulation, however, the re-growth of the cells were demonstrated in the second generation cells which were characterized by accumulation of postsynthetic cells and diminution of postmitotic cells. These results would indicate that Thio Tepa is more effective on Gl or S cells and less effective on G2 cells . 
